References
- Silva GA. Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system. Ann N Y Acad Sci 2010;1199:221–230.
- Piotrovskii, LB, Nanomedicine as a part of nanotechnology. Vestn Ross Akad Med Nauk 2010; 3:41–46.
- Thrall JH. Nanotechnology and medicine. Radiology 2004;230:315–318.
- Chan VS. Nanomedicine: An unresolved regulatory issue. Regul Toxicol Pharmacol 2006;46:218–224.
- De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 2008;3:133–149.
- Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs–a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 2004;113:151–170.
- Lee SH, Lee JE, Baek WY, Lim JO. Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo. J Control Release 2004;96:1–7.
- Wenzel JG, Balaji KS, Koushik K, Navarre C, Duran SH, Rahe CH et al. Pluronic F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle. J Control Release 2002;85:51–59.
- Elan Drug Technologies. Available from: URL: http://www.elandrugtechnologies.com /nanocrystal_technology, 14 July 2011.
- Möschwitzer J, Achleitner G, Pomper H, Müller RH. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm 2004;58:615–619.
- Müller RH, Akkar A. Drug nanocrystals of poorly soluble drugs in Encyclopedia of Nanoscience and Nanotechnology. USA: American Scientific Publishers, 2004: 627–638.
- Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm 2008;354:227–234.
- Coppola D, Nanocrystal technology targets poorly water-soluble drugs. Pharm Techn 2003; 27:20.
- Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm 2005;299:167–177.
- Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 2006;111:56–64.
- Kondo N, Iwao T, Masuda H, Yamanouchi K, Ishihara Y, Yamada N et al. Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region. Chem Pharm Bull 1993;41:737–740.
- Liversidge GG, Conzentino P, Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm 1995; 125:309–313.
- Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–120.
- Möschwitzer J, Müller RH. Spray coated pellets as carrier system for mucoadhesive drug nanocrystals. Eur J Pharm Biopharm 2006;62:282–287.
- Müller RH, Peters K, Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm 1998; 160:229–237.
- Yamada T, Saito N, Imai T, Otagiri M. Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem Pharm Bull 1999;47:1311–1313.
- Yin SX, Franchini M, Chen J, Hsieh A, Jen S, Lee T et al. Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-drying. J Pharm Sci 2005;94:1598–1607.
- Eerdenbrugh BV, Mooter GV, Augustijnsa P, Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 2008; 364 (1):64–75.
- Löbenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000;50:3–12.
- Bernareggi A, Rainsford KD, Nimesulide - Actions and Uses. Basel: Birkhäuser Verlag, 2005:63–115.
- Toutain PL, Cester CC, Haak T, Metge S. Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. J Vet Pharmacol Ther 2001;24:35–42.
- Garbetta NC, Mekmaysya CS, Helmb CW, Jensona AB, Chairesa, JB, Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring. Exp Mol Pathol 2009; 86: 186–191.
- Abdelwahed, W, Degobert, G, Fessi, H, A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol):formulation and process optimization. Int J Pharm 2006; 309:178–188.